Literature DB >> 861142

Plasma uric acid and spironolactone response in healthy subjects.

L E Ramsay, J R Shelton, I R Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861142      PMCID: PMC1429001          DOI: 10.1111/j.1365-2125.1977.tb00706.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  A relationship between plasma uric acid concentration and the apparent response to frusemide in normal subjects.

Authors:  L E Ramsay; M J Tidd; R M Auty; D Levine; R A Branch
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses.

Authors:  L E Ramsay; P Hessian; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

3.  Relative potency of prorenoate and spironolactone in normal man.

Authors:  L Ramsay; I Harrison; J Shelton; M Tidd
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

4.  Determination of uric acid. An adaptation of the Archibald method on the autoanalyzer.

Authors:  H H Nishi
Journal:  Clin Chem       Date:  1967-01       Impact factor: 8.327

5.  A fluorimetric method for the determination of a major spironolactone (Aldactone) metabolite in human plasma.

Authors:  N GOCHMAN; C L GANTT
Journal:  J Pharmacol Exp Ther       Date:  1962-03       Impact factor: 4.030

  5 in total
  2 in total

1.  The influence of sodium and potassium supplements on the diuretic responses to frusemide administration in normal subjects.

Authors:  R A Branch; E Cole; C E Horth; L Jackson; L E Ramsay; J Shelton
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

Review 2.  Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.

Authors:  Thomas Bardin; Pascal Richette
Journal:  BMC Med       Date:  2017-07-03       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.